Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
BlackRock Inc. BLK |
14,078,901 18.100% |
2,160,046 (+18.12%) |
Filing History |
| 2023-01-18 1:30 pm Sale |
2022-12-30 | 13G | Coherus BioSciences, Inc. CHRS |
JPMORGAN CHASE & CO JPM |
5,663,770 7.200% |
-691,417 (-10.88%) |
Filing History |
| 2022-02-14 6:33 pm Purchase |
2021-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
Perceptive Advisors LLC | 5,407,798 7.000% |
735,962 (+15.75%) |
Filing History |
| 2022-02-14 2:45 pm Purchase |
2022-02-14 | 13G | Coherus BioSciences, Inc. CHRS |
ALLIANCEBERNSTEIN L.P. | 5,668,528 7.400% |
1,012,629 (+21.75%) |
Filing History |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
The Vanguard Group | 4,547,529 5.920% |
418,594 (+10.14%) |
Filing History |
| 2022-02-09 12:40 pm Sale |
2021-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
STATE STREET CORP STT |
3,821,120 4.980% |
-797,930 (-17.27%) |
Filing History |
| 2022-01-27 5:14 pm Unchanged |
2021-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
BlackRock Inc. BLK |
11,918,855 15.500% |
0 (Unchanged) |
Filing History |
| 2022-01-26 09:16 am Purchase |
2021-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
BlackRock Inc. BLK |
11,918,855 15.500% |
1,390,505 (+13.21%) |
Filing History |
| 2022-01-07 3:41 pm Purchase |
2021-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
JPMORGAN CHASE & CO JPM |
6,355,187 8.200% |
1,392,505 (+28.06%) |
Filing History |
| 2021-02-16 3:36 pm Purchase |
2020-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
Perceptive Advisors LLC | 4,671,836 6.500% |
1,085,351 (+30.26%) |
Filing History |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
The Vanguard Group | 4,128,935 5.730% |
4,128,935 (New Position) |
Filing History |
| 2021-02-08 08:30 am Purchase |
2020-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
STATE STREET CORP STT |
4,619,050 6.410% |
4,619,050 (New Position) |
Filing History |
| 2021-02-05 6:23 pm Purchase |
2021-02-15 | 13G | Coherus BioSciences, Inc. CHRS |
ALLIANCEBERNSTEIN L.P. | 4,655,899 6.500% |
4,655,899 (New Position) |
Filing History |
| 2021-01-26 2:22 pm Purchase |
2020-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
BlackRock Inc. BLK |
10,528,350 14.600% |
369,351 (+3.64%) |
Filing History |
| 2021-01-08 11:43 am Purchase |
2020-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
JPMORGAN CHASE & CO JPM |
4,962,682 6.800% |
1,494,928 (+43.11%) |
Filing History |
| 2020-10-07 4:30 pm Purchase |
2020-09-29 | 13G | Coherus BioSciences, Inc. CHRS |
Perceptive Advisors LLC | 3,586,485 5.000% |
3,586,485 (New Position) |
Filing History |
| 2020-06-09 4:32 pm Purchase |
2020-05-31 | 13G | Coherus BioSciences, Inc. CHRS |
BlackRock Inc. BLK |
10,158,999 14.300% |
4,486,780 (+79.10%) |
Filing History |